Phlexglobal wins landmark deal with UCB for global electronic trial master file solution
Nicola Murgatroyd, Phlexglobal's founder and chief executive officer, commented: “The UCB contract win is a major achievement for Phlexglobal and will support our rapid expansion, both in the UK and US.”
As part of the contract, Phlexglobal will provide electronic and paper trial master file (TMF) management services for UCB global operations. This will include centralising UCB’s historical and ongoing global clinical study files from Phase I through to Phase IV using Phlexglobal’s PhlexEview solution.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.